BenevolentAI announces first patient dosed in its Atopic Dermatitis clinical trial ...Middle East

LONDON, Feb. 11, 2021 /PRNewswire/ -- BenevolentAI, a leader in the application of AI and machine learning in drug discovery and development, announced dosing of the first patient in its randomised first-in-human clinical trial of BEN-2293, a molecule designed and developed by...

Hence then, the article about benevolentai announces first patient dosed in its atopic dermatitis clinical trial was published today ( Thursday 11/02/2021 - 12:45 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BenevolentAI announces first patient dosed in its Atopic Dermatitis clinical trial )

Also on site :

• Coca-Cola suspended production at its Fairlife dairy after a ransomware attack
• ‘Age of Attraction’ Is Netflix’s Top New Reality Launch, But ‘Star Search’ & ‘Calabasas Confidential’ Struggle
• Martha Stewart's Cloud-Like Slip-on Skechers Are the Perfect Everyday Shoe, and They're 25% Off at JCPenney